To compare hand held ultraviolet device verses whole body ultraviolet device in treatment of vitiligo patient
Not Applicable
- Conditions
- Health Condition 1: L80- Vitiligo
- Registration Number
- CTRI/2019/08/020818
- Lead Sponsor
- AIIMS DELHI
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
a)Consecutive patients of localized vitiligo involving <=2% BSA or <=10 patches.
b)Patients >=18 years of age.
c)Patients who have not taken any topical therapy in last 2 weeks or systemic therapy in last 4 weeks
d)Patients giving consent for using hand held NB-UVB and whole body NB-UVB therapy
Exclusion Criteria
a)Patients with rapidly spreading vitiligo.
b)Patients with recalcitrant forms of vitiligo i.e., lip-tip vitiligo, segmental vitiligo and with predominant leukotrichia on patches.
c)Patients with concomitant photo-aggravated dermatoses.
d)Patients who are unable to maintain the NB-UVB device.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Comparison of percentage of repigmentation of the representative vitiligo patch at the end of 4 months of treatment between the two study groups.Timepoint: over 4 months of treatment
- Secondary Outcome Measures
Name Time Method Comparison of percentage repigmentation in vitiligo <br/ ><br>between the two groups based on global assessment using <br/ ><br>Lund and Browder score <br/ ><br> Assessment ofrepigmentation using photographic <br/ ><br>assessment investigator global assessment <br/ ><br> Comparison of patients perspective of repigmentation in <br/ ><br>vitiligo by Patient global assessment score using <br/ ><br>visual analogue scale from 0-10 <br/ ><br>Change in dermatology life quality index using Tjioe M et <br/ ><br>al questionnaire <br/ ><br> Qualities of life (QOL) score using VIS-22Timepoint: over 4 month of treatment